Oxygen Therapy News and Research

RSS

Oxygen therapy is the administration of oxygen as a medical intervention, which can be for a variety of purposes in both chronic and acute patient care.

Biomarker may predict death or poor pulmonary outcomes in extremely preterm infants

Tests of cells collected from the umbilical cord blood vessel walls at birth can predict death or poor pulmonary outcomes in extremely preterm infants, say researchers at the University of Alabama at Birmingham.

22 May 2017

Clinical trial offers new hope for patients suffering from severe lung disease

Patients suffering from severe lung disease could see their lives transformed thanks to a 'game-changing' clinical trial carried out by UK experts and led by the team from the Lane Fox Respiratory Service based at Guy's and St Thomas' in London.

22 May 2017

Novel way of delivering oxygen therapy may help patients with exacerbation of COPD

A new study finds that delivery of oxygen via high-flow nasal tubes may help patients who experience exacerbations of chronic obstructive pulmonary disease.

4 May 2017

Caffeine may protect lungs from damage caused by prolonged oxygen therapy, study finds

A new study finds that caffeine may protect the lungs from damage caused by prolonged oxygen therapy, such as oxygen supplementation given to premature babies.

8 Mar 2017

Scripps physician first to treat heart attack patients with supersaturated oxygen therapy

A physician at Scripps Health's Prebys Cardiovascular Institute has become the first in the Western United States to treat heart attack patients with a new supersaturated oxygen (SSO2) system in an attempt to reduce permanent damage to their heart muscle.

30 Dec 2016

Mild postoperative pulmonary complications linked to increased mortality risk

Researchers at the University of Colorado Anschutz Medical Campus, along with seven other major institutions, have found that even mild postoperative pulmonary complications (PPCs) are significantly associated with increased death within the first week after surgery.

10 Nov 2016

Long-term oxygen therapy does not benefit COPD patients with moderately low blood oxygen levels

A newly published study of people with chronic obstructive pulmonary disease (COPD) concludes that long-term supplemental oxygen treatment results in little or no change in time to death, time to first hospitalizations or significant quality of life improvements for those with moderately low blood oxygen levels.

27 Oct 2016

Home non-invasive ventilation for COPD: an interview with Dr Holger Woehrle

The key symptom of COPD is breathlessness, especially during daily activity, and the breathlessness is in addition to cough and chest tightness. The difficulty in managing this disease is that it's a disease that progresses with age.

From ResMed Corp 18 Oct 2016

New study reveals benefits of home non-invasive ventilation in improving lives of COPD patients

Today ResMed welcomed positive results from the independent Home Oxygen Therapy- Home Mechanical Ventilation (HOT-HMV) study regarding the benefits of home non-invasive ventilation (NIV).

From ResMed Corp 8 Sep 2016

WSU pharmacologists find hyperbaric oxygen therapy can alleviate opiate withdrawal symptoms

Washington State University researchers have found that treatments of pure oxygen in a high-pressure chamber can relieve the symptoms of opiate withdrawal.

31 Aug 2016

CAIRE adopts new MAP Policy to protect customers' confidence in quality of products

CAIRE Inc., a Chart Industries Company, announced today the implementation of a Minimum Advertised Price Policy (“MAP Policy”) applicable to all distributors, retailers and resellers who advertise or sell CAIRE products over the internet.

31 Aug 2016

IQWiG study: HBOT shows neither hint of benefit nor of harm in people with diabetic foot

If people with a diabetic foot syndrome (DFS) receive hyperbaric oxygen therapy (HBOT) in addition to conventional treatment, this can promote wound healing. However, the certainty of conclusions of the available study results is restricted.

6 Jul 2016

Major improvements to portable oxygen concentrators from CAIRE Inc.

CAIRE Inc., a Chart Industries Company and the global oxygen market leader, has made major improvements to their AirSep® FreeStyle® and FreeStyle 5™ portable oxygen concentrators.

5 Jul 2016

New blood test could help predict severity of pulmonary arterial hypertension

Johns Hopkins Medicine researchers report that rising blood levels of a protein called hematoma derived growth factor (HDGF) are linked to the increasing severity of pulmonary arterial hypertension, a form of damaging high blood pressure in the lungs.

20 Jun 2016

Comprehensive outlook of COPD care in the U.S.

Fifteen million: That's the number of adults in the United States affected by chronic obstructive pulmonary disease, or COPD.

18 May 2016

VolitionRx's NuQ blood test accurately detects 86% of subjects with Idiopathic Pulmonary Fibrosis

VolitionRx Limited today announced preliminary data from a pilot study demonstrating that the Company’s NuQ® blood test detected 86% of subjects with a deadly lung disease, called Idiopathic Pulmonary Fibrosis (IPF).

10 Mar 2016

Selexipag reduces clinical events in PAH patients

Selexipag, alone or in combination with other classes of pulmonary arterial hypertension medication, reduced the composite rate of disease complications and deaths among patients in a phase III trial.

19 Jan 2016

Better coordination could help reduce hospital readmissions, mortality rates

Better coordination between hospitals and post-acute care facilities could reduce patient readmission to hospitals and mortality rates, according to a new study of risk factors by researchers from the University of Colorado School of Medicine.

18 Jan 2016

CareFusion to display new respiratory solutions at AARC Congress

CareFusion, a BD company, will be displaying new respiratory solutions that are designed to put patients first, whether ventilated or breathing on their own, at the American Association for Respiratory Care Congress being held Nov. 7-10 in Tampa, Fla.

6 Nov 2015

Hyperbaric oxygen therapy improves outcomes of umbilical cord blood transplant patients

For the past 27 years, cord blood transplants have been a life-saving treatment option for thousands of people with leukemia, non-Hodgkins lymphoma, Hodgkins disease and myelodysplastic disorders. Cord blood helps replace cancerous blood cells and replenish a patient's own bone marrow and immune system. Even with its success, researchers are continually looking for ways to improve the transplant process and increase cure rates.

24 Sep 2015